Vitrolife AB engages in the development, manufacture, and sale of advanced products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. It operates through the Fertility and Transplantation segments. The Fertility segment works with nutrient solutions, cryopreservation products, and advanced consumable instruments such as needles and pipettes, for the treatment of human infertility. The Transplantation segment involves the development of solutions and systems for assessing and preserving organs in connection with transplantation. The company was founded in 1993 and is headquartered in Gothenburg, Sweden.